44% af patienterne oplevede symptomer, der kunne forbindes med neuropati; de fleste var milde til moderate og var
Forty-four percent of patients experienced symptoms that could be associated with neuropathy; most were mild to moderate and were reversible upon cessation of treatment with TRISENOX.